Combined Therapy against Recurrent Hemangiopericytoma: A Case Report

Department of Oncology, The Third Affiliated Hospital of Soochow University, Changzhou 213003, China A patient with a seven-year history of recurrent metastatic hemangiopericytoma (HPC) was admitted. During his treatment, he received surgical resection, radiotherapy, radiofrequency hyperthermia and...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiao-dong, Jiang, Jing-ting, Wu, Chang-ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chinese Anti-Cancer Association 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643657/
https://www.ncbi.nlm.nih.gov/pubmed/23691471
http://dx.doi.org/10.3969/j.issn.2095-3941.2012.02.012
Descripción
Sumario:Department of Oncology, The Third Affiliated Hospital of Soochow University, Changzhou 213003, China A patient with a seven-year history of recurrent metastatic hemangiopericytoma (HPC) was admitted. During his treatment, he received surgical resection, radiotherapy, radiofrequency hyperthermia and chemotherapy using combined doxorubicin, dacarbazin, vincristine, ginsenoside Rg3, and recombinant human endostatin. This synergistic method provides an encouraging model for treating HPC.

Ejemplares similares